The landscape of dementia prognosis has evolved dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based assessments that could detect Alzheimer's pathology many years before signs and symptoms arise. Although these technological advances characterize exceptional development in knowing neurodegenerative diseases, they ha... https://penaiaa975yhs5.blog-a-story.com/profile